Recombinant Protein Technology: Advancing Biomedical Research and Therapies
Recombinant protein techniques utilize modern molecular biology and biotechnology methods to generate custom proteins for research and medical applications. By isolating and recombining specific genes through genetic engineering, scientists can produce human, animal, and other eukaryotic proteins in abundant quantities. This has revolutionized fields from basic science to new drug development.
DNA Cloning and Protein Expression
The first step in Recombinant Protein production is to isolate the gene encoding the desired protein using genomic DNA or cDNA. Restriction enzymes are used to cut the DNA segment out of a plasmid or vector. This fragment containing the gene of interest is then joined with bacterial, yeast, insect, or mammalian DNA vectors designed to replicate independently of the host chromosome. The recombinant vectors are inserted into appropriate prokaryotic or eukaryotic host cells through transformation or transfection. Once stably integrated, the host's cellular machinery will transcribe and translate the recombinant gene to synthesize and potentially secrete the protein.
Bacterial and Yeast Systems for Protein Synthesis
Prokaryotic cells such as Escherichia coli and yeast strains like Pichia pastoris are popular initial expression systems due to their ease of genetic manipulation, rapid growth, and high productivity. Bacteria are best suited for generating insoluble protein inclusion bodies that require refolding, while yeast favors secretion of correctly folded eukaryotic proteins. Expression tests can rapidly screen for optimal constructs and clones producing high protein yields. However, these simpler hosts may lack post-translational modifications necessary for bioactivity of some eukaryotic proteins.
Mammalian and Insect Cell Expression
More complex human or animal proteins requiring proper folding and post-translational processing are often generated using mammalian or insect cell culture systems. Mammalian cell lines like CHO cells most accurately model human protein processing but have low productivity and difficult scale-up. Baculovirus-infected insect cells strike a balance, correctly modifying many eukaryotic proteins at yields exceeding bacteria or yeast. Protein production levels in either mammalian or insect hosts remain lower than prokaryotes, driving the need for continued optimization.
Get more insights on Recombinant Protein
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian